Shenzhen Mindray Bio-Medical Electronics (SZSE:300760) Could Become A Multi-Bagger
Shenzhen Mindray Bio-Medical Electronics (SZSE:300760) Could Become A Multi-Bagger
If you're not sure where to start when looking for the next multi-bagger, there are a few key trends you should keep an eye out for. Typically, we'll want to notice a trend of growing return on capital employed (ROCE) and alongside that, an expanding base of capital employed. Basically this means that a company has profitable initiatives that it can continue to reinvest in, which is a trait of a compounding machine. And in light of that, the trends we're seeing at Shenzhen Mindray Bio-Medical Electronics' (SZSE:300760) look very promising so lets take a look.
如果您不确定下一个多倍增长器从哪里开始寻找,那么有一些关键趋势您应该注意。通常,我们需要注意成本资本回报率 (ROCE) 的增长趋势,以及随之而来的资本基础的不断扩大。基本上,这意味着公司有利润丰厚的主动项,可以继续投资,这是复合机器的特征。鉴于此,我们在深圳迈瑞医疗电子 (SZSE:300760) 看到的趋势非常有前途,让我们来看看。
Return On Capital Employed (ROCE): What Is It?
资本雇用回报率(ROCE)是什么?
For those that aren't sure what ROCE is, it measures the amount of pre-tax profits a company can generate from the capital employed in its business. To calculate this metric for Shenzhen Mindray Bio-Medical Electronics, this is the formula:
对于那些不确定成本资本回报率 (ROCE) 是什么的人来说,它可以衡量公司从其业务中使用的资本中产生的税前利润额。要为深圳迈瑞医疗电子计算此指标,使用以下公式:
Return on Capital Employed = Earnings Before Interest and Tax (EBIT) ÷ (Total Assets - Current Liabilities)
资产雇用回报率(ROCE)是指企业利润,即企业税前利润除以企业投入的总资本(负债加股权)。如果ROCE高于企业财务成本的承受能力,那么企业就会创造出更多的价值。
0.32 = CN¥13b ÷ (CN¥51b - CN¥11b) (Based on the trailing twelve months to March 2024).
0.32 = CN¥130亿 ÷ (CN¥510亿 - CN¥11b) ( 基于截至 2024 年 3 月的过去十二个月 )。
Thus, Shenzhen Mindray Bio-Medical Electronics has an ROCE of 32%. In absolute terms that's a great return and it's even better than the Medical Equipment industry average of 6.4%.
因此,深圳迈瑞医疗电子的 ROCE 为 32%。绝对金额上,这是一个不错的回报,甚至比医疗设备行业的平均值 6.4% 更好。
![big](https://usnewsfile.moomoo.com/public/MM-PersistNewsContentImage/7781/20240727/0-1b913ebfa6debf771c39c4ef73ef6dd1-0-c3e448c0cf5930cf37d8362105eee365.png/big)
Above you can see how the current ROCE for Shenzhen Mindray Bio-Medical Electronics compares to its prior returns on capital, but there's only so much you can tell from the past. If you're interested, you can view the analysts predictions in our free analyst report for Shenzhen Mindray Bio-Medical Electronics .
您可以看到深圳迈瑞医疗电子目前的 ROCE 与其以前的资本回报率相比如何,但过去只能了解到这么多。如果您感兴趣,可以查看我们为深圳迈瑞医疗电子编写的免费分析师报告中的分析师预测。
What Does the ROCE Trend For Shenzhen Mindray Bio-Medical Electronics Tell Us?
深圳迈瑞医疗电子的 ROCE 趋势告诉我们什么?
Shenzhen Mindray Bio-Medical Electronics is displaying some positive trends. The numbers show that in the last five years, the returns generated on capital employed have grown considerably to 32%. The amount of capital employed has increased too, by 123%. This can indicate that there's plenty of opportunities to invest capital internally and at ever higher rates, a combination that's common among multi-baggers.
深圳迈瑞医疗电子显示出一些积极的趋势。数字表明,在过去五年中,资本回报率增长了相当多,达到了 32%。资本投入增加了123%。这可以表明在内部投资并以更高的速度投资有很多机会,这是多倍增长器的常见组合。
In Conclusion...
最后,同等资本下回报率较低的趋势通常不是我们关注创业板股票的最佳信号。由于这些发展进行良好,因此投资者不太可能表现友好。自五年前以来,该股下跌了32%。除非这些指标朝着更积极的轨迹转变,否则我们将继续寻找其他股票。
In summary, it's great to see that Shenzhen Mindray Bio-Medical Electronics can compound returns by consistently reinvesting capital at increasing rates of return, because these are some of the key ingredients of those highly sought after multi-baggers. And investors seem to expect more of this going forward, since the stock has rewarded shareholders with a 79% return over the last five years. Therefore, we think it would be worth your time to check if these trends are going to continue.
总之,非常高兴看到深圳迈瑞医疗电子可以通过以逐渐增加的回报率持续重新投资资本来复利增长,因为这些都是那些非常抢手的多倍增长器的关键因素之一。而且投资者似乎希望这种情况会持续下去,因为五年里股票已经回报了股东79%。因此,我们认为检查这些趋势是否会持续是值得您的时间的。
If you want to continue researching Shenzhen Mindray Bio-Medical Electronics, you might be interested to know about the 1 warning sign that our analysis has discovered.
如果您想继续研究深圳迈瑞医疗电子,您可能会对我们的分析发现的 1 个警告标志感兴趣。
High returns are a key ingredient to strong performance, so check out our free list ofstocks earning high returns on equity with solid balance sheets.
高回报率是强劲表现的关键因素,因此请查看我们的免费股票列表,其中列出了盈利能力强、资产负债表坚实的股票。
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
对本文有任何反馈?对内容有任何疑虑?请直接与我们联系。或者,发送电子邮件至editorial-team@simplywallst.com。
这篇文章是Simply Wall St的一般性文章。我们根据历史数据和分析师预测提供评论,只使用公正的方法论,我们的文章并不意味着提供任何金融建议。文章不构成买卖任何股票的建议,也不考虑您的目标或您的财务状况。我们的目标是带给您基本数据驱动的长期关注分析。请注意,我们的分析可能不考虑最新的价格敏感公司公告或定性材料。Simply Wall St没有任何股票头寸。
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com
对本文有任何反馈?对内容有任何疑虑?请直接与我们联系。或者,发送电子邮件至editorial-team@simplywallst.com。